Cencora Debt to Equity Ratio 2010-2024 | COR
Current and historical debt to equity ratio values for Cencora (COR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cencora debt/equity for the three months ending September 30, 2024 was 4.84.
| Cencora Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $66.32B | $0.79B | 84.29 |
| 2024-06-30 | $65.71B | $1.06B | 61.96 |
| 2024-03-31 | $62.64B | $1.23B | 51.05 |
| 2023-12-31 | $63.63B | $1.06B | 59.96 |
| 2023-09-30 | $61.89B | $0.67B | 92.89 |
| 2023-06-30 | $60.26B | $0.92B | 65.35 |
| 2023-03-31 | $58.26B | $0.51B | 113.97 |
| 2022-12-31 | $57.83B | $0.07B | 786.22 |
| 2022-09-30 | $56.49B | $0.07B | 792.58 |
| 2022-06-30 | $56.66B | $0.52B | 109.40 |
| 2022-03-31 | $56.40B | $0.91B | 62.25 |
| 2021-12-31 | $56.98B | $0.60B | 94.78 |
| 2021-09-30 | $56.75B | $0.58B | 97.11 |
| 2021-06-30 | $55.52B | $0.41B | 135.94 |
| 2021-03-31 | $47.11B | $-0.10B | -458.31 |
| 2020-12-31 | $46.36B | $-0.51B | -90.62 |
| 2020-09-30 | $45.11B | $-0.84B | -53.73 |
| 2020-06-30 | $36.82B | $3.97B | 9.28 |
| 2020-03-31 | $38.34B | $3.71B | 10.35 |
| 2019-12-31 | $36.95B | $3.07B | 12.04 |
| 2019-09-30 | $36.18B | $2.99B | 12.09 |
| 2019-06-30 | $35.37B | $3.11B | 11.38 |
| 2019-03-31 | $35.77B | $3.04B | 11.77 |
| 2018-12-31 | $36.10B | $3.17B | 11.41 |
| 2018-09-30 | $34.62B | $3.05B | 11.35 |
| 2018-06-30 | $35.03B | $3.28B | 10.69 |
| 2018-03-31 | $35.03B | $3.36B | 10.42 |
| 2017-12-31 | $33.49B | $2.88B | 11.65 |
| 2017-09-30 | $33.25B | $2.06B | 16.11 |
| 2017-06-30 | $32.10B | $2.55B | 12.57 |
| 2017-03-31 | $31.87B | $2.53B | 12.60 |
| 2016-12-31 | $31.80B | $2.12B | 15.03 |
| 2016-09-30 | $31.51B | $2.13B | 14.80 |
| 2016-06-30 | $30.04B | $1.88B | 15.98 |
| 2016-03-31 | $30.30B | $2.19B | 13.83 |
| 2015-12-31 | $29.46B | $1.30B | 22.66 |
| 2015-09-30 | $27.35B | $0.62B | 44.37 |
| 2015-06-30 | $25.76B | $1.58B | 16.35 |
| 2015-03-31 | $25.09B | $1.92B | 13.09 |
| 2014-12-31 | $23.14B | $1.77B | 13.08 |
| 2014-09-30 | $19.58B | $1.96B | 10.00 |
| 2014-06-30 | $18.64B | $1.99B | 9.39 |
| 2014-03-31 | $18.22B | $2.15B | 8.49 |
| 2013-12-31 | $17.55B | $2.25B | 7.81 |
| 2013-09-30 | $16.60B | $2.32B | 7.16 |
| 2013-06-30 | $14.16B | $2.42B | 5.86 |
| 2013-03-31 | $13.77B | $2.35B | 5.87 |
| 2012-12-31 | $13.16B | $2.34B | 5.63 |
| 2012-09-30 | $12.99B | $2.46B | 5.29 |
| 2012-06-30 | $12.82B | $2.93B | 4.38 |
| 2012-03-31 | $12.70B | $2.95B | 4.31 |
| 2011-12-31 | $13.07B | $2.91B | 4.50 |
| 2011-09-30 | $12.12B | $2.87B | 4.23 |
| 2011-06-30 | $11.65B | $3.20B | 3.64 |
| 2011-03-31 | $11.55B | $3.13B | 3.69 |
| 2010-12-31 | $11.17B | $2.96B | 3.77 |
| 2010-09-30 | $11.48B | $2.95B | 3.89 |
| 2010-06-30 | $11.07B | $2.93B | 3.78 |
| 2010-03-31 | $10.99B | $2.83B | 3.88 |
| 2009-12-31 | $10.82B | $2.74B | 3.95 |
| 2009-09-30 | $10.86B | $2.72B | 4.00 |
| 2009-06-30 | $9.95B | $2.78B | 3.57 |
| 2009-03-31 | $9.79B | $2.76B | 3.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $46.783B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $89.358B | 11.09 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| Natera (NTRA) | United States | $20.907B | 0.00 |
| ICON (ICLR) | Ireland | $16.343B | 14.56 |
| Avantor (AVTR) | United States | $15.048B | 22.56 |
| Revvity (RVTY) | United States | $14.408B | 25.03 |
| BioMerieux (BMXMF) | France | $13.788B | 0.00 |
| Viatris (VTRS) | United States | $13.488B | 4.15 |
| Solventum (SOLV) | United States | $12.699B | 0.00 |
| CochLear (CHEOY) | Australia | $12.341B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.485B | 29.54 |
| Doximity (DOCS) | United States | $10.029B | 59.03 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.551B | 0.00 |
| HealthEquity (HQY) | United States | $8.876B | 44.53 |
| Charles River Laboratories (CRL) | United States | $8.361B | 16.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.244B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.118B | 28.46 |
| Organon (OGN) | United States | $4.054B | 4.09 |
| Sotera Health (SHC) | United States | $3.676B | 19.67 |
| BrightSpring Health Services (BTSG) | United States | $3.230B | 68.70 |
| Alignment Healthcare (ALHC) | United States | $2.795B | 0.00 |
| Concentras Parent (CON) | United States | $2.691B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.566B | 29.26 |
| Premier (PINC) | United States | $2.156B | 11.22 |
| PACS (PACS) | United States | $2.106B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.013B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.909B | 0.00 |
| Progyny (PGNY) | United States | $1.788B | 36.21 |
| GoodRx Holdings (GDRX) | United States | $1.742B | 45.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.565B | 0.00 |
| Agilon Health (AGL) | United States | $1.273B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.189B | 11.63 |
| CareDx (CDNA) | United States | $1.150B | 0.00 |
| Embecta (EMBC) | United States | $1.086B | 7.59 |
| AMN Healthcare Services Inc (AMN) | United States | $0.986B | 6.67 |
| Establishment Labs Holdings (ESTA) | $0.968B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.624B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.429B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.426B | 11.15 |
| DocGo (DCGO) | United States | $0.426B | 16.04 |
| Enhabit (EHAB) | United States | $0.402B | 34.74 |
| MultiPlan (MPLN) | United States | $0.260B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.239B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
| Beauty Health (SKIN) | United States | $0.216B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Nutex Health (NUTX) | United States | $0.206B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.181B | 0.00 |
| Biodesix (BDSX) | United States | $0.167B | 0.00 |
| So-Young (SY) | China | $0.110B | 18.60 |
| ModivCare (MODV) | United States | $0.093B | 5.03 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 1.63 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| Oncology Institute (TOI) | United States | $0.042B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |